Table 3.
Five-Year Survival Estimate | Ten-Year Survival Estimate | |||
---|---|---|---|---|
UMMC | UMSC | UMMC | UMSC | |
Overall a | 71.6% (69.8%–73.4%) | 86.8% (84.8%–88.8%) | 52.3% (50.1%–54.5%) | 76.6% (73.7%–79.5%) |
Number of patients | 2763 | 1193 | 2763 | 1193 |
Number of deaths | 784 | 158 | 1144 | 233 |
By Stage | ||||
Stage I b | 92.6% (90.4%–94.8%) | 95.8% (93.8%–97.8%) | 82.7% (79.2%–86.2%) | 89.4% (85.7%–93.1%) |
Number of patients | 597 | 378 | 597 | 378 |
Number of deaths | 44 | 16 | 82 | 31 |
Stage II a | 83.5% (81.1%–85.9%) | 91.2% (88.8%–93.6%) | 64.3% (61.0%–67.6%) | 81.4% (77.5%–85.3%) |
Number of patients | 1038 | 513 | 1038 | 513 |
Number of deaths | 171 | 45 | 306 | 78 |
Stage III a | 62.6% (59.1%–66.1%) | 74.9% (69.4%–80.4%) | 37.9% (34.0%–41.8%) | 59.2% (51.6%–66.8%) |
Number of patients | 746 | 243 | 746 | 243 |
Number of deaths | 279 | 61 | 411 | 83 |
Stage IV c | 23.4% (19.1%–27.7%) | 37.9% (25.4%–50.4%) | 2.5% (0.5%–4.5%) | 14.6% (−1.1%–30.3%) |
Number of patients | 376 | 58 | 376 | 58 |
Number of deaths | 288 | 36 | 343 | 41 |
a Log rank test p-value < 0.001; b Log rank test p-value = 0.036; c Log rank test p-value = 0.005.